Skip to main content

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 330))

Abstract

There are well known differences between children and adults in both the incidence of different types of acute leukemia and the response to treatment. Whereas acute lymphoblastic leukemia (ALL) constitutes 85–90% of cases of acute leukemia in children, the converse is true in adults, approximately 85% of whom have acute myeloid leukemia. There are no proven explanations for this discrepancy in incidence, although it has been postulated that the antigenic stimulation of new clones of lymphocytes during the maturation of the immune system in infants and children may be associated with an increased mutation rate and hence leukemias occurring in cells of lymphoid lineage (1). There are also major differences in responsiveness to therapy, particularly in ALL where there is a progressive age related decline in both initial complete response rate as well as long term disease free survival; adolescents fare more poorly than younger children with subsequent decreases in survival with advancing patient age in adults (Figure l)(2–8).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Greaves, M.F. Speculations on the causes of childhood acute lymphoblastic leukemia. Leukemia 2:120 (1988).

    PubMed  CAS  Google Scholar 

  2. Gaynor, J., Chapman, D., Little, C., McKenzie, S., Miller, W., Andreeff, M., Arlin, Z., Berman, E., Kempin, S., Gee, T., Clarkson, B. A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the memorial hospital experience since 1969. J. Clin. Oncol. 6:1014 (1988).

    PubMed  CAS  Google Scholar 

  3. Baccarani, M., Carbelli, G., Amadori, S., Drenthe-Schonk, A., Willemze, R., Meloni, G., Cardozo, P.L., Haanen, C., Mandelli, F., Tura, S. Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients. Blood 60:677 (1982).

    PubMed  CAS  Google Scholar 

  4. Crist, W., Pullen, J., Boyett, J., Falletta, J., van Eys, J., Borowitz, M., Jackson, J., Dowell, B., Russell, C., Quddus, F., Ragab, A., Vietti, T. Acute lymphoid leukemia in adolescents: clinical and biologic features predict a poor prognosis-a Pediatric Oncology Group study. J. of Clin. Onc. 6:34 (1987).

    Google Scholar 

  5. Linker, C.A., Levitt, L.J., O’Donnell, M., Reis, C.A., Link, M.P., Forman, S.J., Farbstein, M.J. Improved results of treatment of adult acute lymphoblastic leukemia. Blood 69:1242 (1987).

    PubMed  CAS  Google Scholar 

  6. Gottlieb, A.J., Weinberg, V., Ellison, R.R., Henderson, E.S., Terebelo, H., Rafla, S., Cuttner, J., Silver, R.T., Carey, R.W., Levy, R.N., Hutchinson, J.L., Raich, P., Cooper, M.R., Wiernik, P., Anderson, J.R., Holland, J.F. Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by Cancer and Leukemia Group B. Blood 64:267 (1984).

    PubMed  CAS  Google Scholar 

  7. Ellison, P.R., Mick, R., Cuttner, J., Schiffer, C., Sobol, R. Prognostic factors affecting response and survival in adults with acute lymphocytic leukemia treated on CALGB 8011. Proc. Am. Soc. Clin. Oncol. 5:156 (1986).

    Google Scholar 

  8. Hoelzer, D., Thiel, E., Loffler, H., Buchner, T., Ganser, A., Heil, G., Koch, P., Freund, M., Diedrich, H., Ruhl, H., Maschmeyer, G., Lipp, T., Nowrousian, M.R., Burkert, M., Gerecke, D., Pralle, H., Muller, U., Lunscken, C.H., Fulle, H., Ho, A.D., Kuchler, R., Busch, F.W., Schneider, W., Gorg, C.H., Emmerich, B., Braumann, D., Vaupel, H.A., von Paleske, A., Bartels, H., Neiss, A., Messerer, D. Progostic factors in multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71:123 (1988).

    PubMed  CAS  Google Scholar 

  9. Schiffer, C.A., Wade, J.A. Supportive Care: Issues in the use of blood products and treatment of infection. Semin. Oncol. 14:454 (1987).

    PubMed  CAS  Google Scholar 

  10. Mayer, R.J., Schiffer, C.A., Peterson, B.A., Silver, R.T., Cornwell, G.G., Rai, K.R., Ellison, R.R., Maguire, M., Berg, D., Davis, R.B., Mclntyre, O.R., Frei, E. Intensive post-remission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of Ara-C: A progress report from the CALGB. Semin. Oncol. 14:25–31 (1987).

    PubMed  CAS  Google Scholar 

  11. Preisler, H., Davis, R.B., Kirshner, J., Dupre, E., Richards, III F., Hoagland, H.C., Kopel, S., Levy, R.N., Carey, R., Schulman, P., Gottleib, A.J., Mclntyre, O.R., and the Cancer and Leukemia Group B. Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: A Cancer and Leukemia Group B study. Blood 69:1441 (1987).

    PubMed  CAS  Google Scholar 

  12. Rai, K.R., Holland, J.F., Glidewell, O.J., Weinberg, V., Brunner, K., Obrecht, J.P., Preisler, H.D., Nawabi, I.W., Prager, D., Carey, R.W., Cooper, M.R., Haurani, F., Hutchinson, J.L., Silver, R.T., Falkson, G., Wiernik, P., Hoagland, H.C., Bloomfield, C.D., James, G.W., Gottlieb, A., Ramanan, S.V., Blom, J., Nissen, N.I., Bank, A., Ellison, R.R., Kung, F., Henry, P., Mclntyre, O.R., Kaan, S.K. Treatment of acute myelocytic leukemia: a study by Cancer and Leukemia Group B. Blood 58:1203 (1981).

    PubMed  CAS  Google Scholar 

  13. Schiffer, C.A., Mayer, R.J. for CALGB, Cancer and Leukemia Group B (CALGB) Studies in Acute Myeloid Leukemia. In: Acute Myelogenous Leukemia. R.P. Gale (eds), Wiley/Liss (in press).

    Google Scholar 

  14. Berger, R., Bemheim, A., Ochoa-Noguera, M.E., Daniel, M.T., Valensi, F., Sigaux, F., Flandrin, G., Boiron, M. Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: a study of 343 patients. Can. Genet. Cytogenet. 28:293 (1987).

    Article  CAS  Google Scholar 

  15. Fourth International Workshop on Chromosomes in Leukemia, 1982. Clinical significance of chromosomal abnormalities in acute non-lymphoblastic leukemia. Can. Genet. Cytogenet. 11:332 (1984).

    Google Scholar 

  16. Keating, M.J., Cork, A., Broach, Y., Smith, T., Walters, R.S., McCredie, K.B., Trujillo, J., Freireich, E.J. Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leukemia Res. 11:119 (1987).

    Article  CAS  Google Scholar 

  17. Samuels, B.L., Larson, R.A., Le Beau, M.M., Daly, K.M., Bitter, M.A., Vardiman, J.W., Barker, C.M., Rowley, J.D., Golomb, H.M. Specific chromosomal abnormalties in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia 2:79 (1988).

    PubMed  CAS  Google Scholar 

  18. Schiffer, C.A., Lee, E.J., Tomiyasu, T., Wiernik, P.H., Testa, J.R. Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia Blood 73:263 (1989).

    PubMed  CAS  Google Scholar 

  19. Rowley, J.D. Association of specific chromosome abnormalities with type of acute leukemia and with patient age. Can. Res. 41:3407 (1981).

    CAS  Google Scholar 

  20. Golomb, H.M., Alimena, G., Rowley, J.D. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood 60:404 (1982).

    PubMed  CAS  Google Scholar 

  21. Keinänen, M., Griffin, J.D., Bloomfield, C.D., Machnicki, J., de la Chapelle, A. Clonal chromosomal abnormalities showing multiple-cell-lineage involvement in acute myeloid leukemia. New England J Medicine 318:1153 (1988).

    Article  Google Scholar 

  22. Lee, E.J., Pollak, A., Leavitt, R.D., Testa, J.R., Schiffer, C.A. Minimally differentiated acute nonlymphocytic leukemia: A distinct entity. Blood 70:1400 (1987).

    PubMed  CAS  Google Scholar 

  23. Vaughan, W.P., Civin, C.I., Weisenburger, D.D., Karp, J.E., Graham, M.L., Sanger, W.G., Grierson, H.L., Joshi, S.S., Burke, P.J. Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10). Leukemia 2:661 (1988).

    PubMed  CAS  Google Scholar 

  24. Borowitz, M.J., Gockerman, J.P., Moore, J.O., Civin, C.I., Page, S.O., Robertson, J., Bigner, S.H. Clinicopathologic and cytogenetic features of CD34 (My 10)-positive acute nonlymphocytic leukemia. Am. J. Clin. Pathol. 91:265 (1989).

    PubMed  CAS  Google Scholar 

  25. Moscow, J.A., Cowan, K.H. Review: Multidrug resistance. J. Natl. Cancer Inst. 80:14 (1988).

    Article  PubMed  CAS  Google Scholar 

  26. Sobol, R.E., Royston, I., LeBien, T.W., Minowada, J., Anderson, K., Davey, F.R., Cuttner, J., Schiffer, C., Ellison, R.R., Bloomfield, C.D, Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies. Blood 64:730 (1985).

    Google Scholar 

  27. Hoelzer, D., Thiel, E., Loffler, H., Buchner, T., Freund, M., Ganser, A., Heil, G., Hiddemann, W., Maschmeyer, G., Aul, C., Wendt, F.C., Bross, K., Pralle, H., Kuchler, R., Dietrich, H., Mettnernich, M., Lindemann, A., Lipp, T., Kaboth, W., Nowrousian, M.R., Koch, P., Busch, F.W., Heimpel, H., Gotz, G., Weiss, A., Kolb, H., Messerer, D. Intensification chemotherapy and mediastinal irradiation in adult T-cell acute lymphoblastic leukemia. In: R.P. Gale & D. Hoelzer, eds. “Acute Lymphoblastic Leukemia”, New York, p. 221-229 (1990).

    Google Scholar 

  28. Sobol, R.E., Rosemarie, M., Royston, I., Davey, F.R., Ellison, R.R., Newman, R., Cuttner, J., Griffin, J.D., Collins, H., Nelson, D.A., Bloomfield, C.D. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. New Eng. J. Med. 316:1111(1987).

    Article  PubMed  CAS  Google Scholar 

  29. Mirro, J., Zipf, T.F., Pui, C-H., Kitchingman, G., Williams, D., Melvin, S., Murphy, S.B., Stass, S. Acute Mixed Lineage Leukemia: clinicopathologic correlations and prognostic significance. Blood 66:1115 (1985).

    PubMed  CAS  Google Scholar 

  30. Schiffer, C.A. Hybrid Leukemias. In: R.P. Gale & D. Hoelzer, eds. “Acute Lymphoblastic Leukemia”, New York, p. 129-142 (1990).

    Google Scholar 

  31. Ball, E.D., Griffin, J.D., Davis, R., Davey, F.R., Arthur, D., Wurster-Hill, D., Schiffer, C., Bloomfield, C.D. Prognostic value of lymphocyte surface markers in acute myeloid leukemia (AML): A Cancer and Leukemia Group B (CALGB) Study. Blood 72:187 (1988).

    Google Scholar 

  32. Williams, D.L., Raimondi, S.C., Pui, C-H., Rivera, G.K. Evolving chromosome patterns and new cytogenetic concepts in childhood acute lymphoblastic leukemia. In: R.P. Gale & D. Hoelzer, eds. “Acute Lymphoblastic Leukemia”, New York, p. 91-100 (1990).

    Google Scholar 

  33. Williams, D.L., Harber, J., Murphy, S.B., Look, T.A., Kalwinksy, D.K., Rivera, G., Melvin, S.L., Stass, S., Dahl, G.V. Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. Blood 68:205 (1986).

    PubMed  CAS  Google Scholar 

  34. Crist, W., Carroll, A., Shuster, J., Jackson, J., Head, D., Borowitz, M., Behm, F., Link, M., Steuber, P., Ragab, A., Hirt, A., Brock, B., Land, V., Pullen, J. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A pediatric oncology group study. Blood 76:489 (1990).

    PubMed  CAS  Google Scholar 

  35. Bloomfield, C.D., Goldman, A.I., Alimena, G., Berger, R., Borgstrom, G.H., Brandt, L., Catovsky, D., de la Chapelle, A., Dewald, G.W., Garson, O.M., Garwicz, S., Golomb, H.M., Hossfeld, D.K., Lawler, S.D., Mitelman, F., Nilsson, P., Pierre, R.V., Philip, P., Prigogina, E., Rowley, J.D., Sakurai, M., Sandberg, A.A., Secker Walker, L.M., Tricot, G., Van Den Berghe, H., Van Orshoven, A., Vuopio, P., Whang-Peng, J. Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 67:415 (1986).

    PubMed  CAS  Google Scholar 

  36. Kurzrock, R., Gutterman, J.U., Talpaz, M. The molecular genetics of Philadelphia chromosome-positive leukemias. New Eng. J. Med., 319:990 (1988).

    Article  PubMed  CAS  Google Scholar 

  37. Hooberman, A.L., Rubin, C.M., Barton, K.P., Westbrook, C.A. Detection of the Philadelphia chromosome in acute lymphoblastic leukemia by pulsed-field gel electorphoresis. Blood 74:1101 (1989).

    PubMed  CAS  Google Scholar 

  38. Hooberman, A.L., Westbrook, C.A., Davey, F., Schiffer, G., Spino, G., Bloomfield, C.D. Molecular detection of the Philadelphia chromosome (PH1) chromosome in adult acute lymphoblastic leukemia (ALL): clinical cytogenetic, and immunophenotypic correlations in a CALGB study. Blood 74:183 (1989).

    Google Scholar 

  39. Bloomfield, C.D., Wurster-Hill, D., Peng, G., Le Beau, M., Tantravahi, R., Testa, J., Davey, F.R., Ellison, R.R., Cuttner, J., Schiffer, C., Sobol, R.E., Lunghofer, B., Carey, M., Mick, R., Arthur, D. Prognostic significance of the Philadelphia chromosome in adult acute lymphoblastic leukemia. In: R.P. Gale & D. Hoelzer, eds. “Acute Lymphoblastic Leukemia”, New York, p. 101-109 (1990).

    Google Scholar 

  40. Forman, S.J., O’Donnell, M.R., Nademanee, A.P. Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 70:587 (1987).

    PubMed  CAS  Google Scholar 

  41. Evans, W.E., Crom, W.R., Abromowitch, M., Dodge, R., Look, A.T., Bowman, W.P., George, S.L., Pui, C.H. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. New Eng. J. Med. 314:471 (1986).

    Article  PubMed  CAS  Google Scholar 

  42. Lennard, L., Lilleyman, J.S. Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. J. Clin. Oncol. 7:1816 (1989).

    PubMed  CAS  Google Scholar 

  43. Capizzi, R.L., Oliver, L., Friedman, J., Davis, R., Mayer R., Schiffer, C.A. Variations in Ara-C plasma concentrations at steady-state (C-ss) during remission induction and intensification therapy of AML. A population pharmacokinetics study by CALGB. Proc. Amer. Soc. Clin. Onc. 7:57 (1988).

    Google Scholar 

  44. Clavell, L.A., Gelber, R.D., Cohen, HJ., Hitchcock-Bryan, S., Cassady, J.R., Tarbeil, N.J., Blattner, S.R., Tantravahi, R., Leavitt, P., Sallan, S.E. Fouragent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. New Eng. J. Med. 315:657 (1986).

    Article  PubMed  CAS  Google Scholar 

  45. Steinherz, P.G., Gaynon, P., Miller, D.R., Reaman, G., Bleyer, A., Finklestein, J., Evans, R.G., Meyers, P., Steinherz, L.J., Sather, H., Hammond, D. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen — a new intensive therapy protocol: a report from the Children’s Cancer Study Group. J. of Clin. Onc. 4:744 (1986).

    CAS  Google Scholar 

  46. LeBien, T.W., McCormack, T. The common acute lymphoblastic leukemia antigen (CD10): emancipation from a functional enigma. Blood 73:625 (1989).

    PubMed  CAS  Google Scholar 

  47. Barrett, J.A., Horowitz, M.M., Gale, R.P., Biggs, J.C., Camitta, B.M., Dicke, K.A., Gluckman, E., Good, R.A., Herzig, H., Lee, M.B., Marmont, A.M., Masaoka, T., Ramsay, N.K.C., Rimm, A.A., Speck, B., Zwaan, F.E., Bortin, M.M. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 74:862 (1989).

    PubMed  CAS  Google Scholar 

  48. Groopman, J.E., Molina, J.M., Scadden, D.T. Hematopoietic growth factors: biology and clinical applications. New Eng. J. Med. 321:1449 (1989).

    Article  PubMed  CAS  Google Scholar 

  49. Büchner, T., Hiddemann, W., Koenigsmann, M., Zuhlsdorf, M., Wormann, B., Boeckmann, A., van de Loo, J., Maschmeyer, G., Wendt, F., Schulz, G. Human recombinant granulocyte macrophage colony stimulating factor (GM-CSF) for acute leukemias in aplasia and at high risk of early death. Blood 72:111a (1989).

    Google Scholar 

  50. Muhm, M., Andreeff, M., Geissler, K., Gorischek, C., Haas, O., Haimi, J., Hinterberger, W., Schulz, G., Speiser, W., Sunder-Plassmann, G., Valent, P., Lechner, K., Bettelheim, P. RhGM-CSF in combination with chemotherapy — a new strategy in the therapy of acute myeloid leukemia. Blood 74:117a (1989).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schiffer, C.A., McIntyre, O.R. (1993). Age Related Changes in Adults with Acute Leukemia. In: Yang, S.S., Warner, H.R. (eds) The Underlying Molecular, Cellular and Immunological Factors in Cancer and Aging. Advances in Experimental Medicine and Biology, vol 330. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2926-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2926-2_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6270-8

  • Online ISBN: 978-1-4615-2926-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics